Gateway Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Gateway Biotechnology's estimated annual revenue is currently $775k per year.
- Gateway Biotechnology's estimated revenue per employee is $155,000
Employee Data
- Gateway Biotechnology has 5 Employees.
- Gateway Biotechnology grew their employee count by 0% last year.
Gateway Biotechnology's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Project Manager | Reveal Email/Phone |
Gateway Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $79.4M | 512 | 0% | N/A | N/A |
#2 | $1.1M | 7 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 33% | N/A | N/A |
#4 | $5M | 32 | 14% | N/A | N/A |
#5 | $1.1M | 7 | 17% | N/A | N/A |
#6 | $6M | 39 | 3% | N/A | N/A |
#7 | $3.4M | 22 | -8% | N/A | N/A |
#8 | $0.3M | 4 | 0% | N/A | N/A |
#9 | $7.4M | 48 | 50% | N/A | N/A |
#10 | $5.7M | 37 | 0% | N/A | N/A |
What Is Gateway Biotechnology?
With a decade of product development funded by the NIH, we have been testing drug candidates with proven safety records to combat hearing disorders. Our lead product is undergoing a Phase II clinical trial as part of our exclusive contract from the U.S. Army. We have also initiated pre-clinical trials to test the efficacy of three drug candidates to treat tinnitus. Our innovative approach has earned us 7 SBIR/STTR grants, 2 patents, and 5 published papers.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | -17% | N/A |
#2 | $0.4M | 5 | 67% | N/A |
#3 | $0.7M | 5 | 25% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |